SCHEMBL10958968

SCHEMBL10958968

O=C(O)c1cccnc1-n1[se]c2ccccc2c1=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 3/20 0.51
▸ HDAC6 Q9UBN7 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ QSOX1 O00391 1/20 0.51
▸ RGS12 O14924 1/20 0.51
▸ PMM2 O15305 1/20 0.51
▸ PLIN1 O60240 1/20 0.51
▸ GMNN O75496 1/20 0.51
▸ BBOX1 O75936 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ CYBB P04839 1/20 0.51
▸ BCHE P06276 1/20 0.51
▸ GLA P06280 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10956173 0.82 METAP2 (0.53) METAP2HDAC6KDM4EMEN1QSOX1
SCHEMBL5916623 0.82 METAP2 (0.61) METAP2HDAC6KDM4EMEN1QSOX1
SCHEMBL10952636 0.82 METAP2 (0.49) METAP2HDAC6KDM4EMEN1QSOX1
SCHEMBL5916901 0.79 METAP2 (0.54) METAP2HDAC6KDM4EMEN1QSOX1
SCHEMBL30573263 0.79 METAP2 (0.51) METAP2HDAC6KDM4EMEN1QSOX1
SCHEMBL30988556 0.79 METAP2 (0.65) METAP2HDAC6KDM4EMEN1QSOX1
SCHEMBL10873365 0.79 METAP2 (0.65) METAP2HDAC6KDM4EMEN1QSOX1
SCHEMBL5916583 0.76 METAP2 (0.54) METAP2HDAC6KDM4EMEN1QSOX1
SCHEMBL5916849 0.75 LMNA (0.48) METAP2HDAC6KDM4EMEN1QSOX1
SCHEMBL5916782 0.75 METAP2 (0.61) METAP2HDAC6KDM4EMEN1QSOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4550168-A Benzisoselenazolones and a process for the treatment of inflammatory diseases A. NATTERMANN & CIE GMBH (DE) 1985-10-29 — — US disclosed
EP-0100899-A2 Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them A. Nattermann & Cie. GmbH (DE) 1984-02-22 — — EP disclosed
Send feedback